Last updated: 17 June 2019 at 1:46am EST

William End Net Worth




The estimated Net Worth of William End is at least $23.2 Million dollars as of 10 May 2018. William End owns over 9,470 units of Idexx Laboratories stock worth over $15,583,404 and over the last 21 years William sold IDXX stock worth over $7,584,845.

William End IDXX stock SEC Form 4 insiders trading

William has made over 19 trades of the Idexx Laboratories stock since 2011, according to the Form 4 filled with the SEC. Most recently William sold 9,470 units of IDXX stock worth $1,973,169 on 10 May 2018.

The largest trade William's ever made was exercising 9,924 units of Idexx Laboratories stock on 3 May 2016 worth over $264,574. On average, William trades about 2,053 units every 50 days since 2003. As of 10 May 2018 William still owns at least 31,786 units of Idexx Laboratories stock.

You can see the complete history of William End stock trades at the bottom of the page.



What's William End's mailing address?

William's mailing address filed with the SEC is , , , , .

Insiders trading at Idexx Laboratories

Over the last 21 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers, and Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.



What does Idexx Laboratories do?

idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an



What does Idexx Laboratories's logo look like?

Idexx Laboratories, Inc. logo

Complete history of William End stock trades at Idexx Laboratories

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
10 May 2018 William End
Director
Sale 9,470 $208.36 $1,973,169
10 May 2018
31,786
22 Feb 2018 William End
Director
Sale 4,000 $184.48 $737,920
22 Feb 2018
41,256
22 May 2017 William End
Director
Sale 5,000 $162.55 $812,750
22 May 2017
45,256
16 Feb 2017 William End
Director
Sale 5,000 $141.71 $708,550
16 Feb 2017
50,256
10 Feb 2017 William End
Director
Option 6,602 $38.80 $256,158
10 Feb 2017
55,256
8 Nov 2016 William End
Director
Sale 5,000 $109.87 $549,350
8 Nov 2016
48,654
5 Aug 2016 William End
Director
Sale 5,000 $108.50 $542,500
5 Aug 2016
53,564
5 Aug 2016 William End
Director
Sale 5,000 $108.50 $542,500
5 Aug 2016
53,564
3 May 2016 William End
Director
Option 9,924 $26.66 $264,574
3 May 2016
63,578
3 May 2016 William End
Director
Option 9,924 $26.66 $264,574
3 May 2016
63,578
18 May 2015 William End
Director
Sale 3,527 $134.51 $474,417
18 May 2015
26,827
14 May 2015 William End
Director
Option 4,527 $34.37 $155,593
14 May 2015
30,354
10 Mar 2015 William End
Director
Sale 3,500 $150.89 $528,115
10 Mar 2015
25,827
1 Aug 2014 William End
Director
Option 7,934 $39.51 $313,472
1 Aug 2014
29,327
31 Oct 2013 William End
Director
Sale 2,500 $108.32 $270,800
31 Oct 2013
21,393
23 May 2013 William End
Director
Option 4,800 $30.50 $146,400
23 May 2013
23,893
26 Oct 2012 William End
Director
Sale 1,970 $96.21 $189,534
26 Oct 2012
19,093
24 Apr 2012 William End
Director
Sale 3,000 $85.08 $255,240
24 Apr 2012
21,063
26 Apr 2011 William End
Director
Option 8,000 $17.49 $139,920
26 Apr 2011
31,063


Idexx Laboratories executives and stock owners

Idexx Laboratories executives and other stock owners filed with the SEC include: